Cardiovascular
Cardiovascular
-
Cardiovascular | Surgical
RenalGuard Gets Breakthrough Nod to Prevent Cardiac Surgery-Associated AKI
RenalGuard aims to protect the kidneys using personalized, active hydration.Sam Brusco, Associate Editor 01.24.23
-
Cardiovascular
Study: Catheter Ablation Significantly Lowers Dementia Risk in AFib Patients
The Biosense Webster-sponsored trial compared AFib patients treated with catheter ablation to those treated only with anti-arrhythmic drugs.Michael Barbella, Managing Editor 01.24.23
-
Cardiovascular
Kardium's Globe Pulsed Field System is Focus of First-in-Human Study
Patients with paroxysmal AF received pulmonary vein isolation treatment in as little as 16 minutes.Michael Barbella, Managing Editor 01.18.23
-
Cardiovascular
ZOLL Begins REAL SSO2 Post-Market Study
Will evaluate clinical utility and economic value of ZOLL TherOx SSO2 therapy.Sam Brusco, Associate Editor 01.17.23
-
Cardiovascular
Abbott's Navitor TAVI System Earns FDA OK
Navitor is the only self-expanding TAVI system with leaflets in the native valve.Sam Brusco, Associate Editor 01.17.23
-
Cardiovascular
Shockwave Medical to Buy Neovasc for Up to $147M
Neovasc is a developer of minimally invasive devices to treat refractory angina.Sam Brusco, Associate Editor 01.17.23
-
Cardiovascular
Study Data Show Benefits of Medtronic's Renal Denervation System
Results linked the company's Symplicity Spyral denervation product with a statistically significant reduction in office-based blood pressure.Michael Barbella, Managing Editor 01.17.23
-
Cardiovascular | Patient Monitoring
CardiacSense Earns FDA Nod for CSF-3 Medical Watch
The CSF-3 watch measures beat-by-beat heart rate and oxygen saturation of arterial hemoglobin.Sam Brusco, Associate Editor 01.16.23
-
Cardiovascular
Four Studies Demonstrate Clinical, Economic Value of iRhythm’s Product Portfolio
Data show compelling diagnostic and health economic value of the company's Zio product suite across various clinical applications.Michael Barbella, Managing Editor 01.16.23
-
Cardiovascular
Study: Medtronic Cryoablation Significantly Reduces Afib Disease Progression
The Arctic Front cardiac cryoablation catheter led to a 75% reduction in the atrial fibrillation disease progression rate as a first-line therapy.Michael Barbella, Managing Editor 01.16.23
-
Cardiovascular
Inari Medical Enrolls First Patient in DEFIANCE Trial
Will compare outcomes of patients with iliofemoral deep vein thrombosis treated with ClotTriever system vs. anticoagulation only.Sam Brusco, Associate Editor 01.13.23
-
Cardiovascular
HVR Cardio Raises $11M in Series B
HVR Cardio is developing the CathHELIX annuloplasty system to treat mitral regurgitation.Sam Brusco, Associate Editor 01.13.23
-
Cardiovascular
Medtronic Begins Head-to-Head Stent Graft Trial with GORE
Will compare Medtronic's Endurant II/IIs and GORE Excluder AAA device family systems.Sam Brusco, Associate Editor 01.12.23
-
Cardiovascular | Digital Health
Viz.ai Launches AI-Powered Viz Cardio Suite
The solution is tailored for cardiovascular care teams to help improve care pathways and grow referrals.Michael Barbella, Managing Editor 01.12.23
-
Cardiovascular | Digital Health
Tempus Launches Study for its AI-Enabled Predictive Cardiology Tests
The trial aims to determine the impact of detecting patients at increased risk of developing cardiovascular disease.Michael Barbella, Managing Editor 01.11.23
-
Cardiovascular
Michael Lesh Joins Elucid Inc.'s Board of Directors
Lesh is currently the founder/CEO of Syntegra and executive chairman of Cordance Medical.Michael Barbella, Managing Editor 01.11.23
-
Cardiovascular
Viz.ai, Us2.ai Collaborate to Improve Cardiac Care
The two companies will deliver AI-enabled echocardiography decision support with the Viz platform.Michael Barbella, Managing Editor 01.09.23
-
Cardiovascular
First Patient Enrolled in Reflow Medical's IDE Spur Stent Study
Company's Bare Temporary Spur Stent System received Breakthrough Designation status by the FDA in August 2021.Michael Barbella, Managing Editor 01.06.23
-
Cardiovascular | Digital Health
CES 2023: OMRON Healthcare Unveiling New Efforts to Eliminate Heart Attack, Stroke
The U.K. company's remote patient monitoring service will launch early this year.Michael Barbella, Managing Editor 01.06.23
-
Cardiovascular
Volta Medical Raises $38 Million in Series B Funding
Also appoints experienced medical device executive, John Slump, as CFO.Charles Sternberg, Associate Editor 01.05.23
